Leticia E B Vieira, Bayla Ostrach, Salisa Westrick, Korey A Kennelty, Kevin A Look, Delesha M Carpenter
{"title":"Practical naloxone communication tips for pharmacists: Lessons learned from the Linguistic Model of Patient Participation in Care.","authors":"Leticia E B Vieira, Bayla Ostrach, Salisa Westrick, Korey A Kennelty, Kevin A Look, Delesha M Carpenter","doi":"10.1016/j.sapharm.2025.01.014","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Opioid overdose is an ongoing public health issue in the rural United States and can be countered by increasing access to the opioid antagonist naloxone. Community pharmacists are well-positioned to offer and dispense naloxone to patients at risk of opioid overdose, but still experience a range of communication barriers. Understanding rural patient communication preferences is essential to prepare pharmacists to discuss naloxone in a patient-centered manner.</p><p><strong>Objective: </strong>To explore rural community pharmacists' and patients' naloxone communication preferences employing the Linguistic Model of Patient Participation in Care (LM).</p><p><strong>Methods: </strong>In-depth qualitative interviews were conducted with 40 community pharmacists and 40 patients from rural areas in Alabama, Iowa, North Carolina, and Wisconsin. After a thematic analysis of the interview transcripts, three code reports were selected for a secondary qualitative analysis informed by the LM.</p><p><strong>Results: </strong>All elements described in the LM (Predisposing Factors, Enabling Factors, And Provider's Communication Style) were associated with patient-pharmacist naloxone communication. The analysis revealed four additional factors not accounted for in the model: Stigma, Privacy, Insurance Coverage and Price, and Collaboration with Physician.</p><p><strong>Conclusion: </strong>Patient-pharmacist naloxone conversations are impacted by the factors described in the LM, as well as several pharmacy-specific factors which were included in an adapted conceptual model. Future studies should consider these findings when developing interventions to improve patient-pharmacist communication and pharmacists can utilize the practical tips provided to actively address the opioid epidemic.</p>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":" ","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research in Social & Administrative Pharmacy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.sapharm.2025.01.014","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
Practical naloxone communication tips for pharmacists: Lessons learned from the Linguistic Model of Patient Participation in Care.
Background: Opioid overdose is an ongoing public health issue in the rural United States and can be countered by increasing access to the opioid antagonist naloxone. Community pharmacists are well-positioned to offer and dispense naloxone to patients at risk of opioid overdose, but still experience a range of communication barriers. Understanding rural patient communication preferences is essential to prepare pharmacists to discuss naloxone in a patient-centered manner.
Objective: To explore rural community pharmacists' and patients' naloxone communication preferences employing the Linguistic Model of Patient Participation in Care (LM).
Methods: In-depth qualitative interviews were conducted with 40 community pharmacists and 40 patients from rural areas in Alabama, Iowa, North Carolina, and Wisconsin. After a thematic analysis of the interview transcripts, three code reports were selected for a secondary qualitative analysis informed by the LM.
Results: All elements described in the LM (Predisposing Factors, Enabling Factors, And Provider's Communication Style) were associated with patient-pharmacist naloxone communication. The analysis revealed four additional factors not accounted for in the model: Stigma, Privacy, Insurance Coverage and Price, and Collaboration with Physician.
Conclusion: Patient-pharmacist naloxone conversations are impacted by the factors described in the LM, as well as several pharmacy-specific factors which were included in an adapted conceptual model. Future studies should consider these findings when developing interventions to improve patient-pharmacist communication and pharmacists can utilize the practical tips provided to actively address the opioid epidemic.
期刊介绍:
Research in Social and Administrative Pharmacy (RSAP) is a quarterly publication featuring original scientific reports and comprehensive review articles in the social and administrative pharmaceutical sciences. Topics of interest include outcomes evaluation of products, programs, or services; pharmacoepidemiology; medication adherence; direct-to-consumer advertising of prescription medications; disease state management; health systems reform; drug marketing; medication distribution systems such as e-prescribing; web-based pharmaceutical/medical services; drug commerce and re-importation; and health professions workforce issues.